✦ LIBER ✦

Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline

✍ Scribed by Gülay Kenangil; Sibel Özekmekçi; Lale Koldas; Taylan Sahin; Ethem Erginöz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low incidence of restrictive valvulopath

✍ E. Růžička; H. Línková; M. Pěnička; O. Ulmanová; L. Nováková; J. Roth 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 239 KB

Valvular heart disease in patients with

✍ Feriha Ozer; Raziye Tiras; Sibel Cetin; Oya Ozturk; Tuba Aydemir; Serkan Ozben; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 109 KB

2.229 The effect of pergolide and pramip

✍ N. Oztekin; M.F. Oztekin; R. Sarl-Polat; D. Korucu; G. Orhan; F. Ak; M. Saka 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Population pharmacodynamics (PD) of cabe

✍ Fullerton, T.; Forrest, A.; Collins, D.A.; Narang, P.K. 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Efficacy and safety of high-dose cabergo

✍ P. Odin; C. Oehlwein; A. Storch; U. Polzer; G. Werner; R. Renner; M. Shing; A. L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

2.228 Pergolide in the treatment of Park

✍ M. Bares; I. Rektorova; L. Krajcovicova; I. Rektor 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB